ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abortion missed,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
1,2,Anembryonic gestation,Abortion related conditions and complications,Abortions and stillbirth,Preg,N
2,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
4,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
5,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Delivery,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
6,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
7,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7,3,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
8,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
8,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
8,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
9,1,Hyperlactacidaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
9,2,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
9,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
9,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
10,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
10,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
11,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
11,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
11,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
12,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
12,4,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
12,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
14,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
14,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
15,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
15,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
18,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
18,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
19,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
20,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
21,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
22,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
23,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
24,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
26,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
26,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
27,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
27,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
27,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
27,4,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
